SMS Pharmaceuticals Limited
SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.
What SMS files
- Others61
- Updates24
- Important24
- Investor Meet12
- Pledging11
- Board Meeting8
SMS Pharma is holding its 38th AGM where the FY25-26 Annual Report will be presented. The company proposes a dividend of Rs 0.40 per share. Shareholders are advised to update KYC for timely electronic dividend payouts.
SMS Pharma filed its Business Responsibility and Sustainability Report for FY2025-26. Key initiatives include a new `1.9 Cr` CAPEX for advanced effluent treatment, commissioning a 1.3 MW rooftop solar project, and enhancing solvent recovery by 45-50%, significantly cutting hazardous waste. Local sourcing reduced transport-related GHG emissions by ~21 tCO2e.
SMSPHARMA's Board announced a final dividend of Rs. 0.40 per share, subject to shareholder approval. Payment will be post-AGM, with tax deduction at source. Shareholders must submit tax documents by a deadline for correct TDS application.
SMS Pharma's registrar confirmed zero activity on physical share re-lodgement requests. No shareholder requests were received, processed, approved, or rejected. This update signals no recent transfers in this category.
SMS Pharma's 50 lakh new equity shares, issued to promoters via warrant conversion, are now listed and tradable. This equity infusion, valued at Rs. 6.35 Cr, strengthens the company's capital.